Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's version metadata. The study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-29T19:09:06.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5. This reflects an internal release update and does not modify the page's substantive content.
    Difference
    0.1%
    Check dated 2026-08-08T18:41:26.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a minor platform update; no study details or other content appear to have changed.
    Difference
    0.1%
    Check dated 2026-07-25T12:26:04.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The Study Details page now lists Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University as a collaborator and adds a new adverse events outcome (Number of Participants With Adverse Events), along with a defined progression criterion using RECIST v1.0 and a Kaplan-Meier-based follow-up of up to 2 years. The older measure 'Incidence of Adverse Events' and the one-year progression assessment window have been removed.
    Difference
    0.4%
    Check dated 2026-07-11T05:41:52.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a new release of the page. The user-facing content remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:03.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a small update to the page's build. No substantive study details seem to be affected.
    Difference
    0.1%
    Check dated 2026-06-26T22:55:23.000Z thumbnail image

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.